Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. More than 100 treatments are currently on the market, with hundreds more on their way.

Production 237

Production Manufacturing Engineer Containment 237

Pharmaceutical Technology

MARCH 25, 2025

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug manufacturers respond?

Manufacturing 130

Manufacturing Regulation Marketing Drugs 130

Pharmaceutical Technology

JANUARY 21, 2024

CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.

Manufacturing 246

Manufacturing Marketing Development 246

Drug Patent Watch

FEBRUARY 5, 2025

The Latin American Pharmaceutical Market: Why Specialty Generics Are Poised for Growth As the pharmaceutical industry continues to evolve, one trend is becoming increasingly clear: the demand for specialty generics is on the rise, particularly in the Latin American market. What do you think is the future of the pharmaceutical industry?

Marketing 93

Marketing Manufacturing Development 93

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure.

Marketing 242

Marketing Production Branding Manufacturing 242

Pharmaceutical Technology

SEPTEMBER 8, 2023

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

Life Science 244

Life Science Gene Therapy Marketing Gene 244

Bio Pharma Dive

JULY 11, 2022

Gavin Newsom announced a $100 million budget to create a production facility and to develop affordable insulin products, saying the medicines’ high cost “epitomizes market failures.”

Insulin 240

Insulin Manufacturing Production Medicine 240

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. There are also strict price controls, which in some cases can limit profitability for manufacturers. The generics market in Brazil.

Marketing 246

Marketing Sales Production Medicine 246

Drug Patent Watch

JANUARY 13, 2025

As we delve into the intricate world of biosimilar market dynamics, we’ll explore how these complex molecules are reshaping treatment paradigms across diverse patient populations. ”[1] The global biosimilars market is experiencing exponential growth, with projections indicating it will reach $69.4 from 2020 to 2025[1].

Marketing 78

Marketing Insulin Generic Drugs Medicine 78

Bio Pharma Dive

SEPTEMBER 24, 2021

The suits allege an agreement between Merck and a generic manufacturer kept low-cost versions of the drugmaker's widely used Zetia off the market for years.

Manufacturing 306

Manufacturing Drugs Marketing 306

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing 257

Marketing Drugs Research Analyst Manufacturing 257

Bio Pharma Dive

AUGUST 5, 2024

For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.

Branding 264

Branding Manufacturing Medicine Marketing 264

Pharmaceutical Technology

JUNE 23, 2022

In the last year, well-known contract manufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals.

Manufacturing 162

Manufacturing Contract Manufacturing Production Drugs 162

Pharmaceutical Technology

MARCH 11, 2025

The multi-year manufacturing deal with CordenPharma will secure future supply of VK2735 if it goes to market.

Manufacturing 250

Manufacturing Drugs Marketing 250

Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Development 147

Pharmaceutical Technology

JANUARY 25, 2023

The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure’s AVT02 (adalimumab). AVT02, which inhibits tumour necrosis factor, will be marketed as Simlandi in Saudi Arabia. “We The monoclonal antibody AVT02 is the approved biosimilar for AbbVie ’s Humira (adalimumab).

Manufacturing 147

Manufacturing Antibody Marketing Licensing 147

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 7, 2022

The Ayush cluster in Kerala, Care-Keralam Ayurvedic Resource Centre at Koratty in Thrissur, is planning to adopt a multi-pronged strategy to support the small and medium ayurvedic drug manufacturing enterprises (SMEs) by focusing on their production growth and marketing of products.

Marketing 189

Marketing Manufacturing Production Drugs 189

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 Other contributing factors include the decreasing number of post-market studies and difficulties in primary research and manufacturing.

Marketing 173

Marketing Sales Manufacturing Drugs 173

Pharmaceutical Technology

MAY 26, 2023

Chronic disease tech company Convatec Group has partnered with Beta Bionics to manufacture the insulin delivery system iLet Bionic Pancrease. It will now be made at Convatec’s manufacturing sites in Mexico. All three pharma manufacturers of insulin – Novo Nordisk, Sanofi, and Eli Lilly – have since announced price reductions.

Insulin 147

Insulin Manufacturing Pharmacy Marketing 147

Pharmaceutical Technology

JULY 25, 2022

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future. Despite this, specialty generics are expected to be the domain of a handful of companies with the necessary manufacturing capabilities and legal backing needed for entering the market.

Drugs 298

Drugs Manufacturing Production Marketing 298

Worldwide Clinical Trials

NOVEMBER 12, 2024

The process, from patient coordination through manufacturing and administration, is intricate, time-sensitive, and highly regulated. Understanding Cell Therapy Coordination and manufacture of living IP can be as complex as it is rewarding. Operationalizing these trials requires proactive and flawless management at every stage.

Gene Therapy 182

Gene Therapy Clinical Supply Trials Gene 182

Bio Pharma Dive

SEPTEMBER 26, 2022

With supply and labor constraints creating backlogged custom-manufacturing schedules, developers have felt the pain in cost and speed to market.

Gene Therapy 246

Gene Therapy Gene Manufacturing Marketing 246

Pharmaceutical Technology

MARCH 13, 2024

As the demand for medical devices continues to rise, manufacturers are increasingly turning to automation during the assembly process to get their products to market faster. But how can the risks involved be mitigated?

Manufacturing 130

Manufacturing Production Marketing 130

Bio Pharma Dive

OCTOBER 18, 2021

A relatively new class of parenteral drug products on the market - therapeutic oligonucleotides – poses new challenges to the pharmaceutical manufacturing process.

Manufacturing 246

Manufacturing Production Marketing Drugs 246

Bio Pharma Dive

AUGUST 24, 2023

The subsidiary, called Cordavis, will work directly with manufacturers to market or co-produce low-cost biologic drugs, starting with Novartis’ Humira copy.

Drugs 243

Drugs Manufacturing Marketing 243

Pharmaceutical Technology

APRIL 13, 2023

The expanded licence will include the development of vaccines and therapeutic proteins beyond Covid-19 for human and animal health markets in Africa. The initial agreement between Dyadic and Rubic involved discovery, development, manufacturing, and distribution of Covid-19 vaccines by transferring and licensing of C1 platform technology.

Production 279

Production Vaccination Vaccine Protein 279

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 5, 2023

Indian pharma’s mainstay in the areas of CRAMS (contract research and manufacturing services), product development, regulatory protocol adherence, and dossiers submissions in the required CTD (Common Technical Document) format are big growth opportunities, said Suresh Khanna, chairman, Karnataka Drugs and Pharmaceutical Manufacturers Association and (..)

Manufacturing 189

Manufacturing Marketing Production Research 189

Pharmaceutical Technology

APRIL 1, 2025

Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing abroad, becoming the norm?

Manufacturing 130

Manufacturing Marketing 130

Pharmaceutical Technology

NOVEMBER 14, 2022

It remains to be seen if Sunak and Hunt will pursue more fiscally responsible policies that the markets will react favourably to and that will potentially increase the British pound’s value, although early indications suggest that taxes will increase to deal with the national deficit.

Manufacturing 147

Manufacturing Sales Packaging Packaging 147

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. In this post, we'll explore effective strategies for maximizing patent protection and exclusivity, ensuring your product remains a leader in the market.

Marketing 59

Marketing Drugs Production Sales 59

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

XTalks

JANUARY 30, 2025

From a market perspective, the oral liquid segment is anticipated to grow at a compound annual growth rate (CAGR) of approximately 6.5% This versatility eliminates the need to manufacture separate stock-keeping units (SKUs) for each dosage variation, streamlining inventory management and reducing production costs for pharmaceutical companies.

Manufacturing 52

Manufacturing Development Compliance Production 52

Pharmaceutical Technology

JUNE 8, 2023

The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60 years and above. Our strong manufacturing capability and scale, including from our vaccine manufacturing site in Belgium, means we are ready to deliver the vaccine as countries begin to launch.”

Vaccination 147

Vaccination Vaccine Marketing Manufacturing 147

Drug Patent Watch

MARCH 20, 2025

Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. Imagine being able to bring your product to market faster, with reduced costs and increased efficiency.

Production 94

Production Manufacturing Marketing Development 94

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing 96

Licensing Licensing Branding Drugs 96

Pharmaceutical Technology

OCTOBER 23, 2023

On 2 October, Eli Lilly announced that the US Food and Drug Administration (FDA) had issued a complete response letter (CRL) regarding the biologic license application (BLA) for its anti-interleukin (IL)-13 biologic lebrikizumab for the treatment of adults and adolescents (12 and older) with moderate-to-severe atopic dermatitis (AD).

Manufacturing 130

Manufacturing Marketing Licensing Licensing 130

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. The enzymes must be manufactured under cGMP conditions – completely free of animal-derived ingredients.”. Developing best-in-class speciality enzymes.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295